Sera Prognostics (SERA) Other Non Operating Income (2021)
Sera Prognostics (SERA) posted Other Non Operating Income of $1.0 million for Q2 2021.
Sera Prognostics (SERA) Other Non Operating Income (2021) Analysis & Trends
Sera Prognostics' Other Non Operating Income history runs 1 years deep, the most recent figure standing at $1.0 million for Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Sera Prognostics | 102.28 Mn | 102.28 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 1.05 Mn |